Stay updated on Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial
Sign up to get notified when there's something new on the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page.

Latest updates to the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check30 days agoNo Change Detected
- Check37 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference6%
- Check44 days agoChange DetectedThe website has been updated from version 2.14.1 to 2.14.2.SummaryDifference0.3%
- Check58 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check65 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant change in this aspect.SummaryDifference1.0%
- Check95 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page.